You are here
- Home
Glossary
N
- Neoadjuvant hormonal ablation
- Reducing the size of a tumour before surgery or radiotherapy, by the use of hormones.
- Neoadjuvant hormonal therapy
- Therapy (chemotherapy, hormonal therapy or radiotherapy) that is given to a tumour before surgery. Its purpose is to reduce tumour size to aid the surgical procedure and also to kill any cells that might be shed during the operation.
- Neoadjuvant treatments
- Treatments used prior to surgery or radiation.
- Neoplasm
- New growth of tissue or cells; tumour that is generally malignant.
- Neovascularisation
- the formation of new blood vessels in abnormal tissues or in abnormal positions.
- Neurovascular bundles
- nodes that incorporate diffuse collections of neuronal and vascular tissue
- Neutropenic sepsis
- systemic disease associated with a loss of neutrophils
- Nipple inversion
- where the nipple is inverted and points into rather than away from the breast
- Node negative
- Not having cancer present in the lymph nodes.
- Node positive
- With cancer present in the lymph nodes.
- Noncomedo
- ductal carcinoma where cells do not fill the lumen and cannot be expressed by squeezing
- Non-small cell lung cancer (NSCLC)
- the most common form of lung cancer; includes squamous cell carcinoma, large cell carcinoma and adenocarcinoma. Distinct from small cell lung cancer (see below).
- Non-steroidal
- A drug which does not have properties similar to the hormones produced by the adrenal glands (steroids).
- Nucleus
- the 'control centre' of the cell. It contains the chromosomes and thus the entire genetic material of the cell.
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
